Total Investments

$507.93M

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Total Investments

Latest reported$507.93Mperiod endingJun 30, 2026

LGND Quarterly Total Investments ($0.00 → $507.93M)

Quarterly total investments

High-resolution chart · PNG

LGND total investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Investments — Quarterly (USD)
Period ending	Total Investments (USD)
Jun 30, 2026	507,929,000
Mar 31, 2026	797,140,000
Dec 31, 2025	742,177,000
Sep 30, 2025	567,146,000
Jun 30, 2025	392,091,000
Mar 31, 2025	360,140,000
Dec 31, 2024	379,790,000
Sep 30, 2024	368,428,000
Jun 30, 2024	302,452,000
Mar 31, 2024	373,179,000
Dec 31, 2023	258,967,000
Sep 30, 2023	218,309,000
Jun 30, 2023	190,596,000
Mar 31, 2023	193,937,000
Dec 31, 2022	169,864,000
Sep 30, 2022	117,291,000
Jun 30, 2022	142,655,000
Mar 31, 2022	189,006,000
Dec 31, 2021	321,586,000
Sep 30, 2021	299,781,000
Jun 30, 2021	279,972,000
Mar 31, 2021	307,354,000
Dec 31, 2020	363,567,000
Sep 30, 2020	338,154,000
Jun 30, 2020	694,724,000
Mar 31, 2020	654,163,000
Dec 31, 2019	998,324,000
Sep 30, 2019	29,404,000
Jun 30, 2019	42,450,000
Mar 31, 2019	57,552,000
Dec 31, 2018	40,819,000
Sep 30, 2018	996,311,000
Jun 30, 2018	55,609,000
Mar 31, 2018	240,864,000
Dec 31, 2017	6,438,000
Sep 30, 2017	174,657,000
Jun 30, 2017	6,014,000
Mar 31, 2017	155,995,000
Dec 31, 2016	8,345,000
Sep 30, 2016	17,339,000
Jun 30, 2016	64,336,000
Mar 31, 2016	28,118,000
Dec 31, 2015	29,728,000
Sep 30, 2015	125,354,000
Jun 30, 2015	33,996,000
Mar 31, 2015	14,378,000
Dec 31, 2014	0
Sep 30, 2014	-1,574,000
Jun 30, 2014	-1,161,000
Mar 31, 2014	12,275,000
Dec 31, 2013	5,843,000
Sep 30, 2013	8,379,000
Jun 30, 2013	8,579,000
Mar 31, 2013	7,916,000
Dec 31, 2012	8,199,000
Sep 30, 2012	8,407,000
Jun 30, 2012	2,841,000
Mar 31, 2012	1,280,000
Dec 31, 2011	10,000,000
Sep 30, 2011	11,341,000
Jun 30, 2011	30,177,000
Mar 31, 2011	32,547,000
Dec 31, 2010	19,351,000
Sep 30, 2010	21,614,000
Jun 30, 2010	30,301,000
Mar 31, 2010	64,069,000
Dec 31, 2009	37,200,000
Sep 30, 2009	40,374,000
Jun 30, 2009	53,302,000
Mar 31, 2009	49,025,000
Dec 31, 2008	51,918,000
Sep 30, 2008	59,311,000
Jun 30, 2008	55,819,000
Mar 31, 2008	30,685,000
Dec 31, 2007	17,596,000
Sep 30, 2007	29,091,000
Jun 30, 2007	11,789,000
Mar 31, 2007	6,319,000
Dec 31, 2006	13,447,000
Sep 30, 2006	21,862,000
Jun 30, 2006	19,168,000
Mar 31, 2006	17,897,000
Dec 31, 2005	20,174,000
Sep 30, 2005	24,202,000
Jun 30, 2005	35,694,000
Mar 31, 2005	38,449,000
Dec 31, 2004	20,182,000
Sep 30, 2004	34,387,000
Jun 30, 2004	43,958,000
Mar 31, 2004	31,625,000
Dec 31, 2003	40,004,000
Sep 30, 2003	13,744,000
Jun 30, 2003	17,595,000
Mar 31, 2003	21,004,000
Dec 31, 2002	21,825,000
Sep 30, 2002	12,099,000
Jun 30, 2002	17,469,000
Mar 31, 2002	19,431,000
Dec 31, 2001	16,947,000
Sep 30, 2001	21,669,000